The scientific forum for delivering regulated and clinically evaluated digital therapeutics to patients in need, now.
Back even more scientifically stringent, the 2nd Clinically Validated DTx Summit 2019 is dedicated to the development, commercialization and integration of evidence-driven digital therapeutics. Uniting pharma, DTx companies and healthcare institutions, this summit is solely focused on the actionable uses of digital therapeutics that are delivering better patient outcomes.
Tackling a multitude of disease areas and therapeutic modalities, this summit will link R&D innovation to the tangible sustainment of the DTx industry. Hosting clinical and medical data to move beyond the future-focussed hype into the current real world application of DTx, this summit integrates advocacy for the progression of collaboration, partnering and evolution of business models to the benefit these therapeutics can bring to patients worldwide.
What Did 2018 Attendees Have To Say?
“Clinically Validated Digital Therapeutics was one of the most worthwhile conferences I've been to in a long time. There were excellent speakers, debates and it was a pleasure to attend”
Senior Global Digital Director, GSK
“Right of the bat, the inaugural conference on ‘Clinically Validated Digital Therapeutics’ brought together a high quality, deeply engaged audience that is at the core of the Digital Therapeutics movement”
Head of Digital Therapeutics, Novartis Institute for Biomedical Research
“Best networking ever!”
Chief Medical Officer, Tilak Healthcare
“The event brought together leaders from the digital therapeutics space and enabled everyone to have an open and honest discussion about the challenges we're facing, and importantly, how to come together and positively shape our industry!”
Founder & Managing Director, Volar Health
Proud To Partner With